Avelox 400mg Tablets - Moxifloxacin Hydrochloride

Avelox 400mg Tablets - Moxifloxacin Hydrochloride

Avelox 400mg Tablets contain the active ingredient moxifloxacin hydrochloride, a broad-spectrum antibiotic belonging to the fluoroquinolone class. This pharmaceutical product is meticulously formulated to combat a variety of bacterial infections by inhibiting the replication of bacterial DNA, thus impeding the growth and proliferation of bacteria.

Product Specifications:
- Active Ingredient: Moxifloxacin hydrochloride, 400mg per tablet
- Classification: Fluoroquinolone antibiotic
- Administration Route: Oral
- Dosage Form: Film-coated tablet
- Packaging: Blister packs

Common Applications:
- Acute bacterial sinusitis
- Acute bacterial exacerbation of chronic bronchitis
- Community-acquired pneumonia
- Skin and skin structure infections
- Intra-abdominal infections

User Groups:
- Patients with bacterial infections susceptible to moxifloxacin

Supplier Overview:
Bayer is a globally recognized leader in the pharmaceutical and life sciences fields, with a rich history of innovation and development in healthcare and agriculture. As the supplier of Avelox, Bayer leverages its extensive research and development capabilities to ensure the highest quality of antibiotic treatments. Their commitment to patient safety and adherence to stringent regulatory standards positions Bayer as an authoritative figure in the antibiotic product category. With a legacy of over 150 years, Bayer's expertise in the healthcare sector underscores their reliability and trustworthiness as a provider of effective therapeutic solutions like Avelox 400mg Tablets.